Quantamental Technologies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quantamental Technologies’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,999	Closed	-$718K	–	706
2022 Q2	$718K	Buy	+8,999	New	+$852K	0.33%	104
2021 Q4	–	Sell	-3,840	Closed	-$421K	–	530
2021 Q3	$421K	Buy	+3,840	New	+$399K	0.28%	119
2019 Q3	–	Sell	-9,900	Closed	-$238K	–	1998
2019 Q2	$238K	Buy	9,900 +6,569	+197%	+$167K	0.09%	378
2019 Q1	$88K	Buy	+3,331	New	+$78.9K	0.04%	649

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Quantamental Technologies's HZNP Position: Q3 2022 in Review

Quantamental Technologies sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 8,999 shares — an estimated $718K sold.

Quantamental Technologies first reported a position in HZNP in Q1 2019 and held it in 4 quarters. The position peaked at $718K in Q2 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Quantamental Technologies reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Quantamental Technologies sold 8,999 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $718K.
Quantamental Technologies first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 4 quarters.
Quantamental Technologies's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $718K in Q2 2022.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.